Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07205367 · ClinicalTrials.gov registry record · NA
Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II
A NA study of Cardiac Arrhythmia, sponsored by iRhythm Technologies.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT07205367: Active NA study of Cardiac Arrhythmia, sponsored by iRhythm Technologies.
NCT07205367 is a NA study of Cardiac Arrhythmia that is active but no longer recruiting, run by iRhythm Technologies. The registered enrollment target is 150 participants, below the 201-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (25% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07205367, a NA study of Cardiac Arrhythmia, is active but no longer recruiting, sponsored by iRhythm Technologies.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
This trial assesses the wear performance of the Zio monitor, a long-term continuous ambulatory patch ECG monitor, in a representative population by evaluating (1) the wear duration (up to 30 days) of the device, (2) the percentage of analyzable electrocardiographic time and (3) safety by reviewing all adverse events.
Primary Outcome
This outcome measure is met if the mean wear duration is greater than 21 days
Conditions Studied
Interventions
- DEVICE Zio Monitor
Study Locations (2)
California
- iRhythm Technologies - San Francisco, CA - San Francisco
Illinois
- iRhythm Technologies - Deerfield, IL - Deerfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
What the registry record for NCT07205367 still lists
NCT07205367 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 201-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which Zio Monitor is the first listed.
NCT07205367 reports a single indexed study location in California, Illinois.
Frequently Asked Questions
What is clinical trial NCT07205367 about?
NCT07205367 is a clinical study titled "Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II". This trial assesses the wear performance of the Zio monitor, a long-term continuous ambulatory patch ECG monitor, in a representative population by evaluating (1) the wear duration (up to 30 days) of the device, (2) the percentage of analyzable electrocardiographic time and (3) safety by reviewing a...
What is the current status of trial NCT07205367?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-01-06. Estimated completion is 2025-10-31.
What conditions does trial NCT07205367 study?
This clinical trial studies the following conditions: Cardiac Arrhythmia.
What interventions are being tested in trial NCT07205367?
The interventions under investigation include: Zio Monitor (DEVICE).
Who is sponsoring clinical trial NCT07205367?
This trial is sponsored by iRhythm Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07205367 being conducted?
This trial has 2 study locations across California, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrhythmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07205367's enrollment target sits among peer trials
150 4th of 12 higher than 8 of 12 other Cardiac Arrhythmia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrhythmia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals
COMPLETED · NA
-
Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
COMPLETED · NA
-
Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure
COMPLETED · NA
-
SJM MRI Diagnostic Imaging Registry (IDE)
COMPLETED · NA
-
Maestro Handheld Cardiac Monitor Validation
COMPLETED · NA
-
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI